O

OrbiMed Portfolio holdings

AUM $4.17B
1-Year Est. Return 30.9%
This Quarter Est. Return
1 Year Est. Return
+30.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.86B
AUM Growth
+$1.15B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
137
New
Increased
Reduced
Closed

Top Buys

1
+$186M
2
+$115M
3
+$60.8M
4
ABBV icon
AbbVie
ABBV
+$53.1M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$45.4M

Top Sells

1
+$83.2M
2
+$60M
3
+$58.4M
4
UNH icon
UnitedHealth
UNH
+$56.5M
5
CELG
Celgene Corp
CELG
+$53.8M

Sector Composition

1 Healthcare 86.06%
2 Technology 0.09%
3 Financials 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$102M 1.25%
495,000
-218,000
27
$102M 1.25%
1,493,000
+78,900
28
$91.7M 1.13%
1,933,500
-955,000
29
$87.8M 1.08%
5,451,000
+2,820,000
30
$87.2M 1.07%
587,000
-137,000
31
$87.1M 1.07%
2,560,000
+998,600
32
$84.6M 1.04%
2,253,000
+189,900
33
$80.9M 1%
2,012,000
-159,500
34
$75M 0.92%
1,146,600
+313,000
35
$72.4M 0.89%
1,889,000
+687,000
36
$67.7M 0.83%
737,686
-122,570
37
$64.4M 0.79%
1,867,800
-249,848
38
$64.2M 0.79%
3,910,000
+1,781,100
39
$63.8M 0.78%
1,447,200
+1,192
40
$58.6M 0.72%
597,000
-29,000
41
$56.3M 0.69%
4,736,900
-57,400
42
$51.1M 0.63%
626,700
-90,000
43
$47.7M 0.59%
6,693,000
-117,000
44
$42.8M 0.53%
5,372,000
+384,000
45
$41.5M 0.51%
156,507
+69,134
46
$40.6M 0.5%
267,000
+34,100
47
$32M 0.39%
+543,000
48
$31.3M 0.38%
+1,475,100
49
$29.6M 0.36%
6,297,000
+972,000
50
$28.7M 0.35%
5,546,100
+955,300
1
2
3 4 5